期刊
DIABETOLOGIA
卷 60, 期 12, 页码 2534-2535出版社
SPRINGER
DOI: 10.1007/s00125-017-4430-0
关键词
Bladder cancer; Cancer; Empagliflozin; SGLT2 inhibitors; Type 2 diabetes
资金
- Eli Lilly and Company Diabetes Alliance
- Boehringer Ingelheim
分享论文
